Bipolar disorder Genetics and mental health Reference 
Psychiatric Times
JULY 14, 2025
Emerging research on RNA biomarkers, AI applications, and genetic mutations shows promise for developing new diagnostic tools for bipolar disorder. Emerging research on RNA biomarkers, AI applications, and genetic mutations shows promise for developing new diagnostic tools for bipolar disorder.
Psychiatric Times
JULY 1, 2025
SHOW MORE The FDA will update ADHD medication labels, warning of weight loss risks in children under 6, urging careful monitoring by health care professionals. Healthcare professionals should monitor weight and growth in young patients on these medications and consider alternative treatments if adverse effects occur.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Psychiatric Times
JUNE 23, 2025
1 The newly announced CNPV pathway was introduced by FDA Commissioner Marty Makary, MD, MPH, on June 17, 2025, and is intended to expedite reviews for medications that address US public health priorities. The CNPV program, introduced by FDA Commissioner Marty Makary, aims to reduce review times to 1-2 months for eligible applications.
Center for Integrative Psychiatry
JUNE 2, 2025
Mental health is more than just brain chemistry, its deeply intertwined with your biology, lifestyle, and environment. Unlike conventional models that often focus on symptom management, functional psychiatry aims to uncover and address the root causes of mental health challenges.
Mad in America
MAY 17, 2025
However, mental disorders are not concrete things that can be found with a brain scanner or treated with medication like a bacterial infection with antibiotics. Much has already been written about these points, for example in my book on mental health and substance use (open access).
Psychiatric Times
JUNE 18, 2025
Studies in Australia and the United States followed individuals with subthreshold psychotic symptoms and functional decline, along with a genetic risk for schizophrenia, over time. Research indicates that only 20% to 40% of individuals who meet ultra–high risk (UHR) criteria convert to psychosis within 2 to 4 years.
Mad in America
OCTOBER 21, 2023
Thomas Insel, director of the National Institute of Mental Health (NIMH) from 2002-2015, acknowledged in 2011, “Whatever we’ve been doing for five decades, it ain’t working. adults now takes an antidepressant”; however, Time continued, “Mental health is getting worse by multiple metrics. As of late 2022, just 31% of U.S.
Expert insights. Personalized for you.
52 
Let's personalize your content